RHHBF Financials: Roche Holding AG AI Analysis

Home

Stock

RHHBF

Financials

RHHBF Financial

Roche Holding AG

$386.75

0.45%

$1.75

As of today:Mar 25, 13:04:47 GMT-4

Overview Forecast Earnings Dividends Financials

360

Report

Final Score

Key Stats

Prev.Close

$385

Open

$386.75

Day's Range

$386.75 - $386.75

52 week range

$288.89 - $514.08

Volume

Avg.Volume

Dividend yield

EPS (TTM)

20.31

Market Cap

$41.2B

What is Roche Holding Ltd?

Roche Holding AG is a research healthcare company. The company is headquartered in Basel, Basel-Stadt and currently employs 103,249 full-time employees. The company went IPO on 2001-05-04. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

RHHBF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	61,516	61,516	60,495	58,716	63,281	62,801
Revenue Growth (YoY)	2%	2%	3%	-7%	1%	8%
Cost of Revenue	16,230	16,039	15,783	15,626	18,630	19,348
Gross Profit	45,286	45,477	44,712	43,090	44,651	43,453
Selling, General & Admin	13,838	13,721	13,758	13,518	12,130	12,100
Research & Development	--	--	13,042	13,237	14,053	13,707
Operating Expenses	24,118	23,954	24,625	24,561	24,734	24,922
Other Non Operating Income (Expenses)	-1,456	-1,456	-172	-189	-109	-80
Pretax Income	16,973	16,973	11,793	14,079	16,327	17,398
Income Tax Expense	3,174	3,174	2,606	1,721	2,796	2,463
Net Income	12,880	12,880	8,277	11,498	12,421	13,930
Net Income Growth	56%	56%	-28%	-7%	-11%	-3%
Shares Outstanding (Diluted)	803	803	802	804	808	860
Shares Change (YoY)	0%	0%	0%	-1%	-6%	-1%
EPS (Diluted)	16.04	16.03	10.32	14.3	15.37	16.2
EPS Growth	55%	55%	-28%	-7%	-5%	-2%
Free Cash Flow	10,906	10,906	15,085	11,446	13,251	16,427
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	73.61%	73.92%	73.91%	73.38%	70.55%	69.19%
Operating Margin	34.41%	34.98%	33.2%	31.55%	31.47%	29.5%
Profit Margin	20.93%	20.93%	13.68%	19.58%	19.62%	22.18%
Free Cash Flow Margin	17.72%	17.72%	24.93%	19.49%	20.93%	26.15%
EBITDA	21,471	21,826	20,438	18,865	20,295	18,882
EBITDA Margin	34.9%	35.48%	33.78%	32.12%	32.07%	30.06%
D&A For EBITDA	303	303	351	336	378	351
EBIT	21,168	21,523	20,087	18,529	19,917	18,531
EBIT Margin	34.41%	34.98%	33.2%	31.55%	31.47%	29.5%
Effective Tax Rate	18.7%	18.7%	22.09%	12.22%	17.12%	14.15%

Follow-Up Questions

What are Roche Holding AG's key financial statements?



According to the latest financial statement (Form-10K), Roche Holding AG has a total asset of $100,703, Net profit of $12,880

What are the key financial ratios for RHHBF?



Roche Holding AG's Current ratio is 1.5, has a Net margin is 20.93, sales per share of $76.6.

How is Roche Holding AG's revenue broken down by segment or geography?



Roche Holding AG largest revenue segment is Roche Pharmaceuticals, at a revenue of 43,297,000,000 in the most earnings release.For geography, Switzerland is the primary market for Roche Holding AG, at a revenue of 747,000,000.

Is Roche Holding AG profitable?



yes, according to the latest financial statements, Roche Holding AG has a net profit of $12,880

Does Roche Holding AG have any liabilities?



yes, Roche Holding AG has liability of 66,901

How many outstanding shares for Roche Holding AG?



Roche Holding AG has a total outstanding shares of 796

Roche Holding AG (RHHBF) Financial

RHHBF Stock Price Chart